Lenvatinib 1

DRUG2 trials

Sponsors

Peking University

Conditions

Hepatocellular CarcinomaHepatocellular Carcinoma (HCC)Portal Vein Thrombosis

Phase 2

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

CompletedNCT05166239

Peking UniversityHepatocellular Carcinoma, Portal Vein Thrombosis

Start: 2022-01-10End: 2025-12-28Updated: 2026-01-23

Unknown Phase

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

Active, not recruitingNCT07466225

Peking UniversityHepatocellular Carcinoma (HCC)

Start: 2026-05-29End: 2027-06-30Target: 150Updated: 2026-06-09